{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:06:45Z","timestamp":1784531205074,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008021","name":"Fujian University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014125","name":"Fujian Provincial Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274087"],"award-info":[{"award-number":["82274087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016078","name":"Fuzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023-P-005"],"award-info":[{"award-number":["2023-P-005"]}],"id":[{"id":"10.13039\/100016078","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119632","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:33:40Z","timestamp":1782300820000},"page":"119632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comprehensive vasodilatory and antihypertensive effects of 3,7,3\u2032,4\u2032-tetrahydroxyflavone (fisetin): Ex vivo and in vivo evidence"],"prefix":"10.1016","volume":"201","author":[{"given":"Chong Seng","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Yin","family":"Tew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Wei","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Hidayah Kaz","family":"Abdul Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7259-4010","authenticated-orcid":false,"given":"Mun Fei","family":"Yam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2026.119632_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/HYPERTENSIONAHA.119.13437","article-title":"Future of hypertension: the need for transformation","volume":"74","author":"Dzau","year":"2019","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.biopha.2026.119632_bib2","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.4103\/jfmpc.jfmpc_231_19","article-title":"Target organ damage in newly detected hypertensive patients","volume":"8","author":"Prakash","year":"2019","journal-title":"J. Fam. Med. Prim. Care"},{"issue":"5","key":"10.1016\/j.biopha.2026.119632_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/01.HYP.0000145180.38707.84","article-title":"Pathophysiology of Hypertensive Renal Damage: Implications for Therapy","volume":"44","author":"Bidani","year":"2004","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.biopha.2026.119632_bib4","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41371-021-00635-z","article-title":"Hypertension-Mediated Organ Damage and Established Cardiovascular Disease in Patients with Hypertension: The China Hypertension Survey, 2012\u20132015","volume":"36","author":"Wang","year":"2022","journal-title":"J. Human. Hypertens."},{"key":"10.1016\/j.biopha.2026.119632_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.212531","article-title":"Combination Therapy in the Treatment of Hypertension","volume":"7","author":"Guerrero-Garc\u00eda","year":"2018","journal-title":"Drugs Context."},{"issue":"7","key":"10.1016\/j.biopha.2026.119632_bib6","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCRESAHA.118.313294","article-title":"Two-Drug Combinations as First-Step Antihypertensive Treatment","volume":"124","author":"Mancia","year":"2019","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.biopha.2026.119632_bib7","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1007\/s00394-020-02424-9","article-title":"Association between Flavonoid Intake and Risk of Hypertension in Two Cohorts of Australian Women: A Longitudinal Study","volume":"60","author":"Do Rosario","year":"2021","journal-title":"Eur. J. Nutr."},{"issue":"4","key":"10.1016\/j.biopha.2026.119632_bib8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1054\/mehy.2000.1057","article-title":"Dietary Flavonoids and Hypertension: Is There a Link?","volume":"55","author":"Moline","year":"2000","journal-title":"Med. Hypotheses"},{"issue":"18","key":"10.1016\/j.biopha.2026.119632_bib9","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.3390\/molecules25184320","article-title":"The Effects of Flavonoids in Cardiovascular Diseases","volume":"25","author":"Cium\u0103rnean","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.biopha.2026.119632_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/ars.2012.4901","article-title":"Fisetin: A Dietary Antioxidant for Health Promotion","volume":"19","author":"Khan","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.biopha.2026.119632_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11033-018-4450-y","article-title":"Fisetin, a Plant Flavonoid Ameliorates Doxorubicin-Induced Cardiotoxicity in Experimental Rats: The Decisive Role of Caspase-3, COX-II, cTn-I, iNOs and TNF-\u03b1","volume":"46","author":"Ma","year":"2019","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119632_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4062\/biomolther.2015.104","article-title":"Endothelium-Independent E\u1f00ect of Fisetin on the Agonist-Induced Regulation of Vascular Contractility","volume":"24","author":"Je","year":"2016","journal-title":"Biomol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119632_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2121-10-52","article-title":"Role of ERK\/MAPK in Endothelin Receptor Signaling in Human Aortic Smooth Muscle Cells","volume":"10","author":"Chen","year":"2009","journal-title":"BMC Cell. Biol."},{"issue":"2S3","key":"10.1016\/j.biopha.2026.119632_bib14","article-title":"Dietary Supplements for Improving Nitric-Oxide Synthesis","volume":"63","author":"Bonetti","year":"2022","journal-title":"J. Prev. Med. Hyg."},{"issue":"9","key":"10.1016\/j.biopha.2026.119632_bib15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/ani9090623","article-title":"A Review of Endothelium-Dependent and -Independent Vasodilation Induced by Phytochemicals in Isolated Rat Aorta","volume":"9","author":"Knox","year":"2019","journal-title":"Animals"},{"issue":"6","key":"10.1016\/j.biopha.2026.119632_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2613.1999.00137.x","article-title":"Endothelial Nitric Oxide in Humans in Health and Disease","volume":"80","author":"Vallance","year":"1999","journal-title":"Int. J. Exp. Pathol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119632_bib17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/01.RES.87.9.825","article-title":"Mechanisms of NO\/cGMP-Dependent Vasorelaxation","volume":"87","author":"Sausbier","year":"2000","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119632_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1748-1716.2008.01838.x","article-title":"\u03b2 3 -Adrenoceptors Modulate Left Ventricular Relaxation in the Rat Heart via the NO-cGMP-PKG Pathway","volume":"193","author":"Angelone","year":"2008","journal-title":"Acta Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119632_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.krcp.2015.10.004","article-title":"Physiology and Pathophysiology of Cyclooxygenase-2 and Prostaglandin E2 in the Kidney","volume":"34","author":"N\u00f8rregaard","year":"2015","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.biopha.2026.119632_bib20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1100\/tsw.2005.82","article-title":"Adverse Effects of COX-2 Inhibitors","volume":"5","author":"Sharma","year":"2005","journal-title":"Sci. World J."},{"issue":"6","key":"10.1016\/j.biopha.2026.119632_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1078-5884(03)00385-X","article-title":"Prostacyclin: A Vascular Mediator","volume":"26","author":"Vane","year":"2003","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.biopha.2026.119632_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/926968","article-title":"PGI 2 as a Regulator of Inflammatory Diseases","volume":"2012","author":"Dorris","year":"2012","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119632_bib23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1152\/jappl.2001.91.1.497","article-title":"Invited Review: Regulation of Myosin Phosphorylation in Smooth Muscle","volume":"91","author":"Pfitzer","year":"2001","journal-title":"J. Appl. Physiol."},{"issue":"1\u20134","key":"10.1016\/j.biopha.2026.119632_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.prostaglandins.2006.05.010","article-title":"Human Prostacyclin Receptor Structure and Function from Naturally-Occurring and Synthetic Mutations","volume":"82","author":"Stitham","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"10","key":"10.1016\/j.biopha.2026.119632_bib25","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.1167\/iovs.11-7370","article-title":"Identification of the Muscarinic Acetylcholine Receptor Subtype Mediating Cholinergic Vasodilation in Murine Retinal Arterioles","volume":"52","author":"Gericke","year":"2011","journal-title":"Invest. Opthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119632_bib26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jphs.2015.12.005","article-title":"Muscarinic Acetylcholine Receptor M1 and M3 Subtypes Mediate Acetylcholine-Induced Endothelium-Independent Vasodilatation in Rat Mesenteric Arteries","volume":"130","author":"Tangsucharit","year":"2016","journal-title":"J. Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2026.119632_bib27","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1242\/jcs.02805","article-title":"Agonist- and Depolarization-Induced Signals for Myosin Light Chain Phosphorylation and Force Generation of Cultured Vascular Smooth Muscle Cells","volume":"119","author":"Woodsome","year":"2006","journal-title":"J. Cell. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119632_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jash.2008.09.002","article-title":"Vascular Smooth Muscle Cell Signaling Mechanisms for Contraction to Angiotensin II and Endothelin-1","volume":"3","author":"Wynne","year":"2009","journal-title":"J. Am. Soc. Hypertens."},{"key":"10.1016\/j.biopha.2026.119632_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcp.2018.01.017","article-title":"Regulation of Vascular Tone Homeostasis by NO and H2S: Implications in Hypertension","volume":"149","author":"Gheibi","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119632_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5487\/TR.2014.30.3.141","article-title":"Endothelium-Derived Relaxing Factors of Small Resistance Arteries in Hypertension","volume":"30","author":"Kang","year":"2014","journal-title":"Toxicol. Res."},{"issue":"4","key":"10.1016\/j.biopha.2026.119632_bib31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/cvr\/cvy023","article-title":"Vascular Smooth Muscle Contraction in Hypertension","volume":"114","author":"Touyz","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.biopha.2026.119632_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/micc.12046","article-title":"Calcium Dynamics in Vascular Smooth Muscle","volume":"20","author":"Amberg","year":"2013","journal-title":"Microcirculation"},{"issue":"2","key":"10.1016\/j.biopha.2026.119632_bib33","doi-asserted-by":"crossref","first-page":"a006023","DOI":"10.1101\/cshperspect.a006023","article-title":"Signaling in Muscle Contraction","volume":"7","author":"Kuo","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119632_bib34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.advenzreg.2011.09.005","article-title":"Phospholipase C Signaling and Calcium Influx","volume":"52","author":"Putney","year":"2012","journal-title":"Adv. Biol. Regul."},{"issue":"5","key":"10.1016\/j.biopha.2026.119632_bib35","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/fcp.12461","article-title":"Potassium Channels in Vascular Smooth Muscle: A Pathophysiological and Pharmacological Perspective","volume":"33","author":"Dogan","year":"2019","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119632_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/01.ATV.21.1.28","article-title":"Potassium Channel Function in Vascular Disease","volume":"21","author":"Sobey","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2026.119632_bib37","first-page":"147","article-title":"Role of Potassium Channels in the Vascular Response to Endogenous and Pharmacological Vasodilators","volume":"28","author":"Brayden","year":"1991","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.biopha.2026.119632_bib38","series-title":"Advances in Pharmacology","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.apha.2016.07.001","article-title":"Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth","author":"Jackson","year":"2017"},{"issue":"S2","key":"10.1016\/j.biopha.2026.119632_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00878465","article-title":"Pharmacology of the Potassium Channel Openers","volume":"9","author":"Edwards","year":"1995","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"2","key":"10.1016\/j.biopha.2026.119632_bib40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCRESAHA.109.201590","article-title":"Activation and signaling by the AMP-activated protein kinase in endothelial cells","volume":"105","author":"Fisslthaler","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2026.119632_bib41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fphys.2013.00347","article-title":"Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium","volume":"4","author":"Qian","year":"2013","journal-title":"Front. Physiol."},{"issue":"6736","key":"10.1016\/j.biopha.2026.119632_bib42","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/21218","article-title":"Regulation of endothelium-derived nitric oxide production by the protein kinase Akt","volume":"399","author":"Fulton","year":"1999","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.biopha.2026.119632_bib43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0960-9822(99)80371-6","article-title":"The Akt kinase signals directly to endothelial nitric oxide synthase","volume":"9","author":"Michell","year":"1999","journal-title":"Curr. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119632_bib44","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: Regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.biopha.2026.119632_bib45","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/HJH.0000000000000587","article-title":"Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension","volume":"33","author":"Li","year":"2015","journal-title":"J. Hypertens."},{"issue":"11","key":"10.1016\/j.biopha.2026.119632_bib46","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/ph15111416","article-title":"Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold","volume":"15","author":"Abdelgawad","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2026.119632_bib47","doi-asserted-by":"crossref","unstructured":"Razazian, M., Bahiraii, S., Sohail, A., Mandl, M., Jannat, I., Beilhack, G., Alesutan, I., & Voelkl, J. (2025). Fisetin ameliorates vascular smooth muscle cell calcification via DUSP1-dependent p38 MAPK inhibition.","DOI":"10.18632\/aging.206233"},{"issue":"6","key":"10.1016\/j.biopha.2026.119632_bib48","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/j.1476-5381.2011.01476.x","article-title":"The flavonoid scaffold as a template for the design of modulators of the vascular Cav 1.2 channels","volume":"164","author":"Saponara","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119632_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-5922.2010.00212.x","article-title":"Cardiovascular Ion Channels as a Molecular Target of Flavonoids","volume":"28","author":"Scholz","year":"2010","journal-title":"Cardiovasc. Ther."},{"issue":"2\u20133","key":"10.1016\/j.biopha.2026.119632_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tox.2006.01.003","article-title":"Comparative Responses of Rats and Mice Exposed to Linear\/Branched, Linear, or Branched Ammonium Perfluorooctanoate (APFO)","volume":"220","author":"Loveless","year":"2006","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.biopha.2026.119632_bib51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/08958370902934894","article-title":"Immunotoxicity and Hematotoxicity Induced by Tetrachloroethylene in Egyptian Dry Cleaning Workers","volume":"22","author":"Emara","year":"2010","journal-title":"Inhal. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119632_bib52","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tox.2007.11.021","article-title":"The Current State of Serum Biomarkers of Hepatotoxicity","volume":"245","author":"Ozer","year":"2008","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.biopha.2026.119632_bib53","doi-asserted-by":"crossref","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of Chronic Renal Failure: The Nature, Mechanisms, and Potential Consequences","volume":"290","author":"Vaziri","year":"2006","journal-title":"Am. J. Physiol. -Ren. Physiol."},{"key":"10.1016\/j.biopha.2026.119632_bib54","series-title":"Pharmacognosy","first-page":"495","article-title":"Pharmacokinetics","author":"Turfus","year":"2017"},{"issue":"6","key":"10.1016\/j.biopha.2026.119632_bib55","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2125.2004.02194.x","article-title":"The Use of Pharmacokinetic and Pharmacodynamic Data in the Assessment of Drug Safety in Early Drug Development","volume":"58","author":"Walker","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"18","key":"10.1016\/j.biopha.2026.119632_bib56","doi-asserted-by":"crossref","first-page":"14158","DOI":"10.3390\/ijms241814158","article-title":"Fisetin\u2014In Search of Better Bioavailability\u2014From Macro to Nano Modifications: A Review","volume":"24","author":"Szymczak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119632_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118642","article-title":"Improvement Strategies for the Oral Bioavailability of Poorly Water-Soluble Flavonoids: An Overview","volume":"570","author":"Zhao","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119632_bib58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1021\/jf802378q","article-title":"Metabolism and Pharmacokinetics of 3,3\u2032,4\u2032,7-Tetrahydroxyflavone (Fisetin), 5-Hydroxyflavone, and 7-Hydroxyflavone and Antihemolysis Effects of Fisetin and Its Serum Metabolites","volume":"57","author":"Shia","year":"2009","journal-title":"J. Agric. Food Chem."},{"issue":"11","key":"10.1016\/j.biopha.2026.119632_bib59","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.bcp.2011.07.097","article-title":"Fisetin Disposition and Metabolism in Mice: Identification of Geraldol as an Active Metabolite","volume":"82","author":"Touil","year":"2011","journal-title":"Biochem. Pharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:46:56Z","timestamp":1784530016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":59,"alternative-id":["S0753332226006682"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119632","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive vasodilatory and antihypertensive effects of 3,7,3\u2032,4\u2032-tetrahydroxyflavone (fisetin): Ex vivo and in vivo evidence","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119632"}}